Company Filing History:
3 out of 894 
1 out of 5 Years Active: 2005-2009
Title: Gerhard Gross: Innovator in Connective Tissue Repair
Introduction
Gerhard Gross is a notable inventor based in Braunschweig, Germany. He has made significant contributions to the field of biotechnology, particularly in the area of connective tissue repair. With a total of 3 patents, his work has the potential to impact medical treatments and regenerative medicine.
Latest Patents
One of Gross's latest patents is focused on methods of inducing or enhancing connective tissue repair. This invention provides a method for repairing, regenerating, treating, or inducing the repair of an injury, defect, or condition of connective tissue. The method involves inserting engineered cells that contain a nucleic acid encoding a SMAD protein or its variant, which aids in the regeneration and repair of connective tissue. Additionally, this invention includes methods for ex-vivo implantation of engineered cells into affected areas. Another significant patent relates to a recombinant human cell of undifferentiated mesenchyma for bone and cartilage cell formation. This human cell is capable of expressing Tbr-1, Brachyury, or other members of the T-box family, which are crucial for the development of bone and cartilage.
Career Highlights
Throughout his career, Gerhard Gross has worked with various research institutions and companies. Notably, he has been associated with Yissum Research Development Company of the Hebrew University of Jerusalem Ltd. and Gesellschaft für Biotechnologische Forschung mbH. His innovative work has positioned him as a key figure in the biotechnology sector.
Collaborations
Gerhard Gross has collaborated with several professionals in his field, including Dan Gazit and Gadi Turgeman. These collaborations have likely contributed to the advancement of his research and the successful development of his patents.
Conclusion
Gerhard Gross is a prominent inventor whose work in connective tissue repair and biotechnology has the potential to revolutionize medical treatments. His patents reflect a commitment to innovation and improvement in regenerative medicine.